Risk Factors for 30-day Mortality After Emergency Surgery for Non-occlusive Mesenteric Ischemia

Yume Minagawa1,2, Yasuhiro Ishiyama3,2, Manabu Amiki3

  • 1Department of Gastroenterological Surgery, Kawasaki Saiwai Hospital, Kawasaki, Japan; mngw710yume.va@gmail.com.

In Vivo (Athens, Greece)
|August 28, 2025
PubMed
Abstract

Insights

Non-occlusive mesenteric ischemia (NOMI) is a severe condition. Chronic kidney disease, hemodialysis, high lactate dehydrogenase (LDH), and low platelet count are key risk factors for 30-day mortality after emergency surgery for NOMI.

Area of Science:

  • Gastroenterology
  • Vascular Surgery
  • Critical Care Medicine

Background:

  • Non-occlusive mesenteric ischemia (NOMI) is a rare, highly fatal condition.
  • It involves intestinal ischemia or necrosis without mesenteric vessel obstruction.
  • NOMI poses significant challenges in emergency surgical settings.

Purpose of the Study:

  • To identify risk factors for 30-day mortality in patients undergoing emergency surgery for NOMI.
  • To analyze patient characteristics and outcomes associated with NOMI survival.
  • To determine predictors of early death following NOMI surgical intervention.

Main Methods:

  • Retrospective analysis of 42 consecutive patients with NOMI undergoing emergency surgery.
  • Patients were categorized into 30-day mortality (n=9) and survival (n=33) groups.
  • Comparison of patient demographics, medical history, surgical outcomes, and laboratory values between groups.

Main Results:

  • The overall 30-day mortality rate for NOMI was 21.4%.
  • Patients with 30-day mortality showed higher prevalence of chronic kidney disease (CKD) and hemodialysis.
  • Lower platelet counts and elevated preoperative lactate dehydrogenase (LDH) >1,127 U/l were significantly associated with mortality.

Conclusions:

  • Chronic kidney disease (CKD) and hemodialysis are significant risk factors for NOMI mortality.
  • Elevated lactate dehydrogenase (LDH) levels and low platelet counts independently predict early death in NOMI patients.
  • These findings aid in risk stratification and management of NOMI patients undergoing emergency surgery.

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
20
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
24
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24